Company Overview of Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc., a neuroscience-focused clinical stage biopharmaceutical company, is engaged in developing a novel medicine for major depressive disorders and alcohol use disorders. The company offers amitifadine, a serotonin-preferring triple reuptake inhibitor that acts on serotonin, norepinephrine, and dopamine in a specific ratio for treating major depressive disorders. Euthymics Bioscience, Inc. was founded in 2009 and is based in Cambridge, Massachusetts.
43 Thorndike Street
Cambridge, MA 02141
Founded in 2009
Key Executives for Euthymics Bioscience, Inc.
Similar Private Companies By Industry
|Velius, LLC||United States|
|Pugliese Pharmaceutical Services, LLC||United States|
|Cyterix Pharmaceuticals Inc.||United States|
|Ortek Therapeutics Inc.||United States|
|VeroScience, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Euthymics Bioscience, Inc., please visit euthymics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.